Ayana M. Jordan | |
---|---|
Born | Ayana Martina Jordan |
Education |
|
Scientific career | |
Fields | Addiction psychiatry, immunopathology |
Institutions |
Ayana Jordan is an American addiction psychiatrist and immunopathologist. She researches treatments for substance use disorders in marginalized communities. She is the Barbara Wilson Associate Professor of Psychiatry at NYU Langone Health and was a professor at Yale School of Medicine. She served as an attending psychiatrist in the Yale University Department of Psychiatry. She was elected to the Board of Trustees of the American Psychiatric Association in 2018. She attended Hampton University and received her MD and PhD from the Albert Einstein College of Medicine.
Ayana Jordan was born in Pittsburgh, Pennsylvania, and grew up in Pittsburgh's Hill District. Her family moved to a white neighbourhood when she was 12. She won the Pennsylvania Junior Academy of Science multiple times. [1]
Jordan attended Hampton University, a historically Black university, graduating with a BS in biology in 2001. She earned her MS in pathology from the Albert Einstein College of Medicine of Yeshiva University in 2006. She received her PhD in immunopathology in 2009 and her MD in 2011, both from the Albert Einstein College of Medicine. She was a member of the Delta Sigma Theta sorority [2] and served as president of the Einstein chapter of the Physicians for a National Health Program. [3]
In 2011, Jordan joined the faculty of Yale School of Medicine as an assistant professor and addiction psychiatrist. During her residency, she established an internship program for students from Common Ground High School in New Haven. [4] She became the chief resident in psychiatry in 2014. At Yale School of Medicine, Jordan served as the director of Social Justice and Health Equity curriculum for the department of psychiatry. [5] For a time she was the faculty's sole Black woman psychiatrist. [6]
In 2016, Jordan was honored as a fellow and became an attending psychiatrist at the Yale University Department of Psychiatry. [7] In 2017, she joined the Yale University Department of Psychiatry as the director of their Social Justice and Health Equity Curriculum. She was hired by the Connecticut Mental Health Center as director of their Medication for Addiction Treatment Consultation Center in 2018. She became the Associate Psychiatry Residency Program Director at Yale in 2020. Jordan was hired as the Barbara Wilson Associate Professor of Psychiatry at NYU Langone Health in 2021. [8]
Jordan specializes in addiction, global mental health, and mental health in marginalized communities. Her research centers on treatment for substance use disorders, especially in underserved communities. [9]
In 2017, Jordan joined Yale School of Medicine psychiatry professor Chyrell Bellamy to design the Imani Breakthrough Project. The project collaborated with Latino and Black churches in Connecticut as venues for the treatment of substance abuse. [10] [11] The program included 12 weeks of classes and wellness coaching for its participants. Patients were connected with providers of medication-assisted treatment prescriptions. [12]
In 2018, Jordan published a study with Keturah James demonstrating that the frequency of deaths from opioids was increasing with white people less than it was with Black people. [13] She received her first NIH R01 grant in 2020. [1]
In 2020, Jordan worked with U.S. Representative Rosa DeLauro to secure funding for a program addressing racial disparities in the treatment of drug and alcohol addiction. The program, "Computer Based Training for Cognitive Behavioral Therapy", targeted the Black community in New Haven, Connecticut, and was hosted by the Dixwell Avenue Congregational United Church of Christ. [14] Jordan provides treatment for methadone users in Connecticut [15] and studied rule changes allowing methadone users to administer the medication at home during the COVID-19 pandemic. [16]
Jordan was a senior author of a 2021 study published in Lancet Psychiatry that found that minority patients suffering from depression or anxiety had unmet needs for healthcare practitioners who were culturally competent. [17]
Jordan was part of a team of researchers who conducted analyses of data collected on overdoses in California during the COVID-19 pandemic. [18] She was a lead author in a 2022 study published in JAMA Psychiatry examining racial disparities in the impact of the pandemic. [19] Jordan's research group also conducts studies of drug use and holds training sessions for the use of naloxone. [20]
Jordan has studied mental health in Sierra Leone. In a 2015 deportation trial for a former child soldier from the country, she told the judge that returning him to Sierra Leone would likely result in him being stigmatized and suffering a psychotic episode. [21] She has also participated in faith-based summits on mental health. [22]
As a science communicator, Jordan has written articles and provided commentary on subjects relating to mental health and addiction. Topics she has addressed include fentanyl, [23] cannabis use disorder, [24] treatments for methamphetamine users, [25] Narcan use, [20] the portrayal of addiction in the television series Euphoria , [26] the link between suicide and substance abuse disorders, [27] follow-up care for patients who screen positive for depression, [28] excited delirium, [29] the viability of SPECT scans for assessing alcohol-related brain damage, [30] and racial disparities in the prescription of addiction treatments [31] and overdose deaths. [9] As part of the #ShareTheMic campaign in 2020, Jordan took over the Twitter account of bariatric surgeon Arghavan Salles. [32]
In 2020, Jordan reviewed an analysis of racial disparities in prescription drug use published in JAMA Psychiatry for The New York Times . She cited corporate marketing strategies and physician bias as factors that contribute to attributed racial disparities in the duration of treatment for buprenorphine. [33]
Jordan was elected to the Board of Trustees of the American Psychiatric Association as its Early Career Psychiatrist Trustee-at-Large in 2018. [34] [35] She received the Yale School of Medicine's Psychiatry Residents' Association Faculty Diversity Award in 2021. [36]
Jordan is Christian. [22] During the COVID-19 pandemic, she hosted virtual Black Trivia Nights with music from live DJs. [2]
Sally L. Satel is an American psychiatrist based in Washington, D.C. She is a lecturer at Yale University School of Medicine, a visiting professor of psychiatry at Columbia University, a senior fellow at the American Enterprise Institute, and an author.
Addiction medicine is a medical subspecialty that deals with the diagnosis, prevention, evaluation, treatment, and recovery of persons with addiction, of those with substance-related and addictive disorders, and of people who show unhealthy use of substances including alcohol, nicotine, prescription medicine and other illicit and licit drugs. The medical subspecialty often crosses over into other areas, since various aspects of addiction fall within the fields of public health, psychology, social work, mental health counseling, psychiatry, and internal medicine, among others. Incorporated within the specialty are the processes of detoxification, rehabilitation, harm reduction, abstinence-based treatment, individual and group therapies, oversight of halfway houses, treatment of withdrawal-related symptoms, acute intervention, and long term therapies designed to reduce likelihood of relapse. Some specialists, primarily those who also have expertise in family medicine or internal medicine, also provide treatment for disease states commonly associated with substance use, such as hepatitis and HIV infection.
Nora Volkow is a Mexican-American psychiatrist. She is currently the director of the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH).
Psychiatry is the medical specialty devoted to the diagnosis, prevention, and treatment of deleterious mental conditions. These include various matters related to mood, behaviour, cognition, and perceptions.
The Citizens Commission on Human Rights International (CCHR) is a nonprofit organization established in 1969 by the Church of Scientology and psychiatrist Thomas Szasz, headquartered in Los Angeles, California. Its stated mission is to "eradicate abuses committed under the guise of mental health and enact patient and consumer protections." Many critics regard it as a Scientology front group whose purpose is to push the organization's anti-psychiatric agenda.
Herbert David Kleber was an American psychiatrist and substance abuse researcher. His career, centered on the evidence-based treatment of addiction, focused on scientific approaches in place of punishment and moralisms. His career focused on pathology of addiction to help patients reduce the severe discomforts of withdrawal, avoid relapse and stay in recovery.
Jeffrey Alan Lieberman is an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscience (biology) and pharmacological treatment. He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing pharmacotherapies for schizophrenia. He was president of the American Psychiatric Association from May 2013 to May 2014.
Substance use disorder (SUD) is the persistent use of drugs despite substantial harm and adverse consequences as a result of their use. The National Institute of Mental Health (NIMH) states that “Substance use disorder (SUD) is a treatable mental disorder that affects a person's brain and behavior, leading to their inability to control their use of substances like legal or illegal drugs, alcohol, or medications. Symptoms can be moderate to severe, with addiction being the most severe form of SUD”. Substance use disorders (SUD) are considered to be a serious mental illness that fluctuates with the age that symptoms first start appearing in an individual, the time during which it exists and the type of substance that is used. It is not uncommon for those who have SUD to also have other mental health disorders. Substance use disorders are characterized by an array of mental/emotional, physical, and behavioral problems such as chronic guilt; an inability to reduce or stop consuming the substance(s) despite repeated attempts; operating vehicles while intoxicated; and physiological withdrawal symptoms. Drug classes that are commonly involved in SUD include: alcohol, caffeine, cannabis, hallucinogens, inhalants, opioids, sedatives, hypnotics or anxiolytics, stimulants, tobacco
Addiction psychiatry is a medical subspecialty within psychiatry that focuses on the evaluation, diagnosis, and treatment of people who have one or more disorders related to addiction. This may include disorders involving legal and illegal drugs, gambling, sex, food, and other impulse control disorders. Addiction psychiatrists are substance use disorder experts. Growing amounts of scientific knowledge, such as the health effects and treatments for substance use disorders, have led to advancements in the field of addiction psychiatry. These advancements in understanding the neurobiology of rewarding behavior, along with federal funding, has allowed for ample opportunity for research in the discipline of addiction psychiatry. Addiction psychiatry is an expanding field, and currently there is a high demand for substance use disorder experts in both the private and public sector.
Mark S. Gold is an American physician, professor, author, and researcher on the effects of opioids, cocaine, tobacco, and other drugs as well as food on the brain and behavior. He is married to Janice Finn Gold.
Psychiatry is, and has historically been, viewed as controversial by those under its care, as well as sociologists and psychiatrists themselves. There are a variety of reasons cited for this controversy, including the subjectivity of diagnosis, the use of diagnosis and treatment for social and political control including detaining citizens and treating them without consent, the side effects of treatments such as electroconvulsive therapy, antipsychotics and historical procedures like the lobotomy and other forms of psychosurgery or insulin shock therapy, and the history of racism within the profession in the United States.
Carolyn M. Mazure is an American psychologist and the Norma Weinberg Spungen and Joan Lebson Bildner Professor of Psychiatry and Psychology at the Yale School of Medicine. She created and directs Women’s Health Research at Yale — Yale’s interdisciplinary research center on health and gender.
In the United States, the opioid epidemic is an extensive, ongoing overuse of opioid medications, both from medical prescriptions and illegal sources. The epidemic began in the United States in the late 1990s, according to the Centers for Disease Control and Prevention (CDC), when opioids were increasingly prescribed for pain management, resulting in a rise in overall opioid use throughout subsequent years. The great majority of Americans who use prescription opioids do not believe that they are misusing them.
Elinore F. McCance-Katz is an American physician, academic, and government official who served as Assistant Secretary of Health and Human Services for Mental Health and Substance Use from 2017 to 2021. Prior to assuming her current role, she was the chief medical officer for the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities, and Hospitals and a professor at the Alpert Medical School at Brown University. Her nomination was supported by the American Psychiatric Association, which released a statement saying "Dr. McCance-Katz has a wealth of experience in academic and public sector settings in addressing mental health and substance use disorders."
Bandy Xenobia Lee is an American psychiatrist whose scholarly work includes the writing of a comprehensive textbook on violence. She is a specialist in public health approaches to violence prevention who consulted with the World Health Organization and initiated reforms at New York's Rikers Island Correctional Facility. She helped draft the United Nations chapter on "Violence Against Children," leads a project group for the World Health Organization's Violence Prevention Alliance, and has contributed to prison reform in the United States and around the world. She taught at Yale School of Medicine and Yale Law School from 2003 through 2020.
Professor Henrietta Bowden-Jones OBE is a medical doctor, Psychiatrist, Honorary Professor at University College London and Honorary Senior Visiting Fellow, Dept of Psychiatry at Cambridge University.
The opioid epidemic, also referred to as the opioid crisis, is the rapid increase in the overuse, misuse/abuse, and overdose deaths attributed either in part or in whole to the class of drugs called opiates/opioids since the 1990s. It includes the significant medical, social, psychological, demographic and economic consequences of the medical, non-medical, and recreational abuse of these medications.
Marc Nicholas Potenza is an American psychiatrist who specializes in addiction psychiatry. He is Professor of Psychiatry, Child Study and Neurobiology at the Yale University School of Medicine, where he also serves as director of the Problem Gambling Clinic and the Center of Excellence in Gambling Research. He is also the director of the Women and Addictive Disorders Core of Women's Health Research and the Program for Research on Impulsivity and Impulse Control Disorders, both at Yale University.
Anna Lembke is an American psychiatrist who is Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic at Stanford University. She is a specialist in the opioid epidemic in the United States, and the author of Drug Dealer, MD, How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop. Her latest book, a New York Times bestseller, Dopamine Nation: Finding Balance in the Age of Indulgence, was released in August 2021.